We are live on ! Find out more
CKPT

Checkpoint Therapeutics
CKPT

Delisted

CKPT was delisted on the 29th of May, 2025.

Back to rankings

70 hedge funds and large institutions have $50.6M invested in Checkpoint Therapeutics in 2021 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 27 increasing their positions, 17 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more call options, than puts

Call options by funds: $4K | Put options by funds: $1K

100% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 8

65% more capital invested

Capital invested by funds: $30.7M → $50.6M (+$19.9M)

59% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 17

13% more funds holding

Funds holding: 62 → 70 (+8)

0.4% more ownership

Funds ownership: 1.98% → 2.38% (+0.4%)

Holders
70
Holders Change
+8
Holders Change %
+12.9%
% of All Funds
1.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
27
Reduced
17
Closed
8
Calls
$4K
Puts
$1K
Net Calls
+$3K
Net Calls Change
+$3K

Top Buyers

Rank Fund Capital Flow
1
OM
Opaleye Management
Massachusetts
+$9.81M
2
JSMC
Jess S. Morgan & Co
California
+$2M
3
SAG
Spotlight Asset Group
Illinois
+$1.92M
4
Deutsche Bank
Deutsche Bank
Germany
+$1.36M
5
BlackRock
BlackRock
New York
+$1.02M

Top Sellers

Rank Fund Capital Flow
1
CH
CVI Holdings
Delaware
-$1.69M
2
Millennium Management
Millennium Management
New York
-$862K
3
Morgan Stanley
Morgan Stanley
New York
-$389K
4
Wells Fargo
Wells Fargo
California
-$294K
5
Legal & General Group
Legal & General Group
United Kingdom
-$148K
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
26
Wells Fargo
California
$157K -$294K -8,758 -64%
UBS Group
27
UBS Group
Switzerland
$152K +$128K +3,813 +374%
Barclays
28
Barclays
United Kingdom
$136K +$89K +2,656 +159%
Bank of America
29
Bank of America
North Carolina
$130K +$69.6K +2,077 +101%
FAM
30
Fenimore Asset Management
New York
$102K – – –
New York State Common Retirement Fund
31
New York State Common Retirement Fund
New York
$97K – – –
RhumbLine Advisers
32
RhumbLine Advisers
Massachusetts
$89K -$8.08K -241 -8%
Invesco
33
Invesco
Georgia
$89K +$11K +327 +13%
VF
34
Virtu Financial
New York
$83K +$17.6K +525 +25%
OAM
35
Occidental Asset Management
California
$83K +$88.5K +2,640 New
VOYA Investment Management
36
VOYA Investment Management
Georgia
$82K +$14.9K +446 +21%
Goldman Sachs
37
Goldman Sachs
New York
$78K -$140K -4,171 -63%
Manulife (Manufacturers Life Insurance)
38
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$77K -$9.45K -282 -10%
PPA
39
Parametric Portfolio Associates
Washington
$69K -$6.37K -190 -8%
RJFSA
40
Raymond James Financial Services Advisors
Florida
$60K +$64.2K +1,916 New
TC
41
Tatro Capital
Kentucky
$58K – – –
Man Group
42
Man Group
United Kingdom
$53K +$57K +1,700 New
FAIM
43
Financial Advocates Investment Management
Washington
$47K – – –
PAM
44
PVG Asset Management
Colorado
$46.7K +$49.8K +1,487 New
TRCT
45
Tower Research Capital (TRC)
New York
$44K +$20K +596 +74%
ProShare Advisors
46
ProShare Advisors
Maryland
$43K +$8.01K +239 +21%
ECM
47
ExodusPoint Capital Management
New York
$43K +$45.7K +1,363 New
Osaic Holdings
48
Osaic Holdings
Arizona
$39K +$9.45K +282 +29%
Envestnet Asset Management
49
Envestnet Asset Management
Illinois
$38K +$570 +17 +1%
XT
50
XTX Topco
Cayman Islands
$37K +$39.7K +1,184 New
1
2
3 4

CKPT Hedge Fund Activity: Q1 2021 in Review

70 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Checkpoint Therapeutics (CKPT) for Q1 2021, worth a combined $50.6M — up 65% from $30.7M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new CKPT positions and 8 closed out — a net gain of 8 holders — while 27 added to existing stakes and 17 trimmed.

The largest buyer was Opaleye Management, opening a new position worth an estimated $9.81M. The largest seller was CVI Holdings, exiting entirely with an estimated $1.69M sold.

  • 70 institutional investors held Checkpoint Therapeutics (CKPT) as of Q1 2021, up from 62 in Q4 2020.
  • Funds reported $50.6M of Checkpoint Therapeutics stock for Q1 2021, up 65% quarter-over-quarter.
  • 16 funds opened new Checkpoint Therapeutics positions in Q1 2021 and 8 closed out, a net change of +8 holders.
  • The largest Checkpoint Therapeutics buyer in Q1 2021 was Opaleye Management, an estimated $9.81M added.
  • The largest Checkpoint Therapeutics seller in Q1 2021 was CVI Holdings, an estimated $1.69M sold.

Based on aggregated 13F filings for Q1 2021.